SIMPLIFY EXCHANGE TRADED FUN - HEALTH CARE ETF (PINK)

CUSIP: 82889N772

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / HEALTH CARE ETF
Total 13F shares
542,902
Share change
+278,510
Total reported value
$12,894,374
Price per share
$23.75
Number of holders
21
Value change
+$6,541,439
Number of buys
12
Number of sells
8

Security key

82889N772

Report period

Q3 2022

Institutions

21

Top holders

10

Ownership snapshot

Top shareholders of PINK - SIMPLIFY EXCHANGE TRADED FUN - HEALTH CARE ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
21
Shares
542,902
Rows loaded
21
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
14
Q3 2022 holders
21
Holder diff
7
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .